Location History:
- Travis, TX (US) (2003 - 2004)
- Austin, TX (US) (1997 - 2013)
- Houston, TX (US) (2016 - 2018)
Company Filing History:
19 out of 5,463 
5 out of 636 
1 out of 1 
Years Active: 1997-2018
Title: John T. McDevitt: Pioneering Innovations in Bioanalysis
Introduction
John T. McDevitt, located in Austin, TX, is a prominent inventor renowned for his contributions to the fields of biotechnology and bioanalysis. With a remarkable portfolio of 24 patents, McDevitt's work focuses primarily on innovative technologies that enhance point-of-care testing and drug screening.
Latest Patents
Among his latest inventions is the patent for "Integrated instrumentation for the analysis of biofluids at the point-of-care." This invention showcases a bead-based lab-on-a-chip portable analyzer designed for analyzing biomarker assay cards used in point-of-care testing. Another significant contribution is the "Bio-nano-chips for on-site drug screening" technology. This bio-nano-chip (BNC) system integrates with non-invasive samples such as saliva, cheek swabs, or urine. It enables easy testing performed by individuals without specialized training, including security personnel and police officers. The microfluidic drug testing system includes a housing unit with a slot for a cartridge, an analyzer with a user-friendly interface, and mechanisms for fluid movement.
Career Highlights
John McDevitt has held influential positions at esteemed institutions, including the University of Texas System and Rice University. His work in these prestigious environments has led to groundbreaking advancements in bioinstrumentation and point-of-care diagnostics.
Collaborations
Throughout his career, McDevitt has collaborated with other innovative minds, including Eric V. Anslyn and Jason B. Shear. Their collective expertise has fostered an environment of creativity and has driven successful research projects that push the boundaries of biotechnological advancements.
Conclusion
John T. McDevitt exemplifies the spirit of innovation within the biotechnology sector. With his extensive patent portfolio and a commitment to improving analytical methods in healthcare, he continues to influence both academic research and practical applications in the field. His dedication to advancing technology at the point-of-care paves the way for improved diagnostics and drug testing in everyday settings.